These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19820295)

  • 1. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.
    Selimoglu H; Duran C; Kiyici S; Ersoy C; Guclu M; Ozkaya G; Tuncel E; Erturk E; Imamoglu S
    J Endocrinol Invest; 2010 Apr; 33(4):234-8. PubMed ID: 19820295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
    Menichini D; Facchinetti F
    Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
    Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
    Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
    Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
    Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
    Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between vitamin D, glucose homeostasis and androgen level among polycystic ovary syndrome patients: a cross-sectional study.
    Li Y; Wang J; Yang J; Chen J; Zhou W; Qiao C; Shen S; Bi Y
    Gynecol Endocrinol; 2021 Mar; 37(3):235-239. PubMed ID: 33576294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
    J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders.
    Acién P; Quereda F; Matallín P; Villarroya E; López-Fernández JA; Acién M; Mauri M; Alfayate R
    Fertil Steril; 1999 Jul; 72(1):32-40. PubMed ID: 10428145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.